Stock Markets Analysis & Opinion

Healthcare Realty Trust Incorporated (NYSE:HR) announced that it will acquire an array of 15 Atlanta-based medical office buildings as per its prior agreement. The properties, totaling 1.3 million...

Much has been happening with ViaSat Inc. (NASDAQ:VSAT) in recent times. The company recently launched the ViaSat-2 satellite, which has immense prospects. Just a couple of days ago, ViaSat released...

Per a National Federation of Independent Business report released August 9, 2017, small business activity improved in July. The index increased to 105.2 in July compared with 103.6 in June and was...

Tetragon Financial Group Ltd (AS:TFG) reported a 2.8% NAV total return for H117, with positive contributions made by all asset classes in the portfolio. Although below the target 10-15% range,...

4SC (BS:G4Sc) is a Munich-based cancer biopharmaceutical company. In this interview Jason Loveridge, CEO of 4SC, provides an overview of the company, its recent equity capital raise (€41m gross)...

Earlier this month premium global eCommerce solutions provider, Pitney Bowes Inc. (NYSE:PBI) , reported its second-quarter 2017 results, which came in below expectations. The company reverted to its...

Investors seeking momentum may have First Trust Hong Kong AlphaDEX Fund FHK on radar now. The fund recently hit a 52-week high. Shares of FHK are up approximately 15.2% from the 52-week low of...

Intrexon Corporation (NYSE:XON) incurred loss of 16 cents per share in the second quarter of 2017, which was narrower than the Zacks Consensus Estimate loss of 21 cents.Total revenue came in at...

Investors continually seek out investments and securities that provide significant growth prospects, yet stability for their principal. Say cheers! Many alcoholic beverage stocks possess opportunities...

Gogo Inc. (NASDAQ:GOGO) reported second-quarter 2017 loss of 56 cents per share, which was wider than the Zacks Consensus Estimate of a loss of 49 cents.However, revenues increased 17.1% from...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported a loss of 5 cents per share in the second quarter of 2017, narrower than both the Zacks Consensus Estimate as well as the year ago loss of 6...

Perrigo Company plc (NYSE:PRGO) reported second-quarter 2017 earnings of $1.22 per share, which beat the Zacks Consensus Estimate of 95 cents per share by 28.4%. However, adjusted earnings declined...

(0:40) - Brand Value Investing Strategy(3:00) - How To Find The Strongest Company Brands(5:00) - BVAL Overview: Sector Breakdown, Unrealized Value and Market Cap(9:30) - ACSI: Customer Satisfaction ...

The Medicines Company (NASDAQ:MDCO) reported second-quarter 2017 loss of $5.52 per share, massively wider than the Zacks Consensus Estimate of a loss of $1.29.However, adjusted loss per share was...